Lagos R , Kotloff K , Hoffenbach A , et al. Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infants.[J]. Pediatric Infectious Disease Journal, 1998, 17(4):294-304.
 Data on file /E2I03294 /Open,randomised，comparative trial of the immunogenicity and safety of two.Immunization schedules ( 2,3,4 months and 2,4,6 months of age) using diphtheria, tetanus, acellular pertussis, polio (DTacP-IPV) vaccine mixed with Haemophilus influenzae type b ( AcT-HIB) vaccine.
 LI R C,LI F X,LI Y P,et al.Immunogenicity and Safety of a DTaP-IPV//PRP-T Combined Vaccine (Pentaxim) at 2,3,4 months or 3,4,5months versus separate vaccines (DTaP,PRP-T and IPV) in healthy Chinese infants.13th Asian Pacific Congress of Pediatrics,2009,Ab.E2142．
 LI R C,LI F X,LI Y P,et al.Antibody persistence at 18-20 months of age following primary vaccination of healthy infants with a Combined DTaP-IPV/ /PRP-T Vaccine (Pentaxim) compared to separate vaccines (DTaP,PRP-T,and IPV) and immunogenicity and safety of booster vaccination in the Peoples’Republic of China 5th Asian Congress of Pediatric Infectious Diseases,Taipei,Taiwan.2010.
J H Kang, H J Lee, K H Kim, et,al. The Immunogenicity and Safety of a Combined DTaP-IPV//Hib Vaccine Compared with Individual DTaP-IPV and Hib (PRP~T) Vaccines: A Randomized Clinical Trial in South Korean Infants. J Korean Med Sci 2016; 31: 1383-1391.